Skip to main content
Premium Trial:

Request an Annual Quote

Kailos Expands Partnership With US DoD on Genetic Identification for Counter-Terrorism

NEW YORK (GenomeWeb) – Genetic testing firm Kailos Genetics announced today that it has expanded its existing partnership with the US Department of Defense's Combating Terrorism Technical Support Office (CTTSO).

Under the terms of the agreement, Kailos will continue developing a laboratory and software solution for analysis and identification of genetic material, for the purposes of counter-terrorism.

"Through enriching and deeply sequencing DNA samples, we can uncover information to positively impact the work being done by federal investigative agencies," Kailos CSO Troy Moore said in a statement.

The DoD established the CTTSO in 1999, with a mission to "identify and develop capabilities to combat terrorism and irregular adversaries and to deliver these capabilities to DoD components and interagency partners."

Kailos, based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama, said it reached several milestones set by the CTTSO to verify the credibility of its targeted genetic sequencing methods, including complete sequencing of hundreds of genetic samples, some of which had been genotyped by alternative methodologies.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.